Report for Potter AS

General

Full name : Potter Alexandra S

First name : Alexandra S

Mail : University of Vermont College of Medicine, Burlington, VT

Zip Code :

City :

Country : USA

Email : Alexandra.Potter@uvm.edu

Phone :

Fax :

Website :

Directory :

References (8)

Title : AZD3480, a Novel Nicotinic Receptor Agonist, for the Treatment of Attention-Deficit\/Hyperactivity Disorder in Adults - Potter_2014_Biol.Psychiatry_75_207
Author(s) : Potter AS , Dunbar GC , Mazzulla E , Hosford D , Newhouse PA
Ref : Biological Psychiatry , 75 :207 , 2014
Abstract : Potter_2014_Biol.Psychiatry_75_207
ESTHER : Potter_2014_Biol.Psychiatry_75_207
PubMedSearch : Potter_2014_Biol.Psychiatry_75_207
PubMedID: 23856296

Title : A randomized, double-blind, placebo-controlled crossover study of alpha4beta 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit\/hyperactivity disorder - Jucaite_2014_Psychopharmacology.(Berl)_231_1251
Author(s) : Jucaite A , Ohd J , Potter AS , Jaeger J , Karlsson P , Hannesdottir K , Bostrom E , Newhouse PA , Paulsson B
Ref : Psychopharmacology (Berl) , 231 :1251 , 2014
Abstract : Jucaite_2014_Psychopharmacology.(Berl)_231_1251
ESTHER : Jucaite_2014_Psychopharmacology.(Berl)_231_1251
PubMedSearch : Jucaite_2014_Psychopharmacology.(Berl)_231_1251
PubMedID: 23640072

Title : Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity - Potter_2012_Psychopharmacology.(Berl)_220_331
Author(s) : Potter AS , Bucci DJ , Newhouse PA
Ref : Psychopharmacology (Berl) , 220 :331 , 2012
Abstract : Potter_2012_Psychopharmacology.(Berl)_220_331
ESTHER : Potter_2012_Psychopharmacology.(Berl)_220_331
PubMedSearch : Potter_2012_Psychopharmacology.(Berl)_220_331
PubMedID: 21969123

Title : Functional brain imaging of nicotinic effects on higher cognitive processes - Newhouse_2011_Biochem.Pharmacol_82(8)_943
Author(s) : Newhouse PA , Potter AS , Dumas JA , Thiel CM
Ref : Biochemical Pharmacology , 82 :943 , 2011
Abstract : Newhouse_2011_Biochem.Pharmacol_82(8)_943
ESTHER : Newhouse_2011_Biochem.Pharmacol_82(8)_943
PubMedSearch : Newhouse_2011_Biochem.Pharmacol_82(8)_943
PubMedID: 21684262

Title : Poster: A Phase IIa trial assessing the effects of AZD1446 on two cohorts of adult Attention Deficit Hyperactivity Disorder (ADHD) patients: Users and non-users of nicotine-containing products -
Author(s) : Newhouse PA , Steiert JC , Prater JF , Heussy JK , Oskooilar N , Potter AS , Hannesdottir K , Jaeger J , Ohd J , Brogren J , Sweitzer D , Garcia DJ
Ref : Biochemical Pharmacology , 82 :1044 , 2011
PubMedID:

Title : Effects of acute ultra-low dose mecamylamine on cognition in adult attention-deficit\/hyperactivity disorder (ADHD) - Potter_2009_Hum.Psychopharmacol_24_309
Author(s) : Potter AS , Ryan KK , Newhouse PA
Ref : Hum Psychopharmacol , 24 :309 , 2009
Abstract : Potter_2009_Hum.Psychopharmacol_24_309
ESTHER : Potter_2009_Hum.Psychopharmacol_24_309
PubMedSearch : Potter_2009_Hum.Psychopharmacol_24_309
PubMedID: 19475630

Title : Acute nicotine improves cognitive deficits in young adults with attention-deficit\/hyperactivity disorder - Potter_2008_Pharmacol.Biochem.Behav_88_407
Author(s) : Potter AS , Newhouse PA
Ref : Pharmacol Biochem Behav , 88 :407 , 2008
Abstract : Potter_2008_Pharmacol.Biochem.Behav_88_407
ESTHER : Potter_2008_Pharmacol.Biochem.Behav_88_407
PubMedSearch : Potter_2008_Pharmacol.Biochem.Behav_88_407
PubMedID: 18022679

Title : Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit\/hyperactivity disorder? - Potter_2006_Behav.Brain.Res_175_201
Author(s) : Potter AS , Newhouse PA , Bucci DJ
Ref : Behavioural Brain Research , 175 :201 , 2006
Abstract : Potter_2006_Behav.Brain.Res_175_201
ESTHER : Potter_2006_Behav.Brain.Res_175_201
PubMedSearch : Potter_2006_Behav.Brain.Res_175_201
PubMedID: 17081628